A doctor admitted lying in order to practise medicine in Ireland including Donegal because he feared for his livelihood.Dr Failsal Siddiqui blamed pressure from the murder of his younger brother in Pakistan and the subsequent death of his father from grief for the events that led to him covering up disciplinary proceedings taken against him in the UK.Dr Siddiqui, who has worked as an orthopaedic surgeon in hospitals in Cork, Kerry, Waterford, Drogheda and Donegal said he regrets his lie ‘every day’ and prays for forgiveness. The Pakistani born doctor faces one allegation of professional misconduct before a fitness to practise inquiry for failing to reveal in his application for Irish registration as a doctor in June 2011, that the UK’s General Medical Council had imposed conditions on his registration two months earlier.It arose out of a complaint made by a patient at Kingston Hospital, London after Dr Siddiqui treated the man’s ruptured Achilles tendon by placing his leg in a cast.He has told the inquiry that he failed to turn up to proceedings against him in the UK because of the extraordinary pressure he was under at the time.His barrister Rosemary Mallon requested that the Medical Council take in to consideration the desperate circumstances of Dr Siddiqui found himself in when considering if he should be found guilty of professional misconduct. “It was and mistake and it was poor judgement. There’s no malice, there’s no greed here. This was done because he was in desperate circumstances and desperate times,” Ms Mallon said. DOCTOR ADMITS LYING TO PRACTISE IN CO DONEGAL was last modified: October 10th, 2013 by StephenShare this:Click to share on Facebook (Opens in new window)Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Reddit (Opens in new window)Click to share on Pocket (Opens in new window)Click to share on Telegram (Opens in new window)Click to share on WhatsApp (Opens in new window)Click to share on Skype (Opens in new window)Click to print (Opens in new window) Tags:doctordonegalIrish Medical Councilpractise
Benfica are being linked with a move for Taye Taiwo.The Nigerian left-back, who spent the second half of last season on loan at QPR from AC Milan, expects to leave the San Siro on a permanent basis this summer.“If Benfica are considering signing me for the next season, then I can only thank them for showing an interest in me,” Taiwo was quoted as saying by O Jogo.“My plan is to develop and improve myself every year and next season it will also be like that. Benfica would be a good club for me to develop and improve myself.”This page is regularly updated.Follow West London Sport on Twitter Find us on Facebook
Trials have shown that rates of HIV infection are reduced if people not infected with HIV take anti-retrovirals – known as pre-exposure prophylaxis (PrEP). Just two African countries have approved PrEP for now: South Africa and Kenya.Pre-exposure prophylaxis is providing an exciting new innovation to tackle HIV prevention.Linda-Gail BekkerThe rate of HIV infection remains greater than the number of people initiating treatment. This imbalance will stop the eradication of HIV/AIDS. It begs for increased investment into primary prevention.Primary prevention caters to people who are HIV negative. It aims to reduce their chance of becoming infected. There are certain populations, now referred to as key populations, in whom the burden of infection is disproportionately high. These include men who have sex with men, sex workers, people who inject drugs, transgender people, and, in sub-Saharan Africa, adolescent girls and young women. Primary prevention should be tailored, and scaled up, for these groups.Primary prevention can be provided in a number of ways. But the most exciting new innovation is pre-exposure prophylaxis (PrEP). PrEP is the use of anti-retrovirals by HIV-uninfected people to prevent HIV transmission. It is commonly given as a daily pill (sold as Truvada) to be taken orally in the same way that contraceptives are used to prevent pregnancy or antimalarial pills are taken before travelling to a high malaria risk area.Numerous clinical trials and demonstration projects in diverse settings and populations have been conducted with PrEP all showing that it works. PrEP is easy to take. It is also largely side effect free and safe. There is one hitch: it has to be taken consistently at the time of HIV exposure. Adherence has been oral PrEP’s biggest stumbling block.That’s why a huge effort is being made to find alternative ways to take PrEP. New formulations in the pipeline include long-acting injections, monthly vaginal rings, implants and topical gels, films and dissolving topical pills. The hope is that new formulations will make PrEP more accessible and convenient, particularly for adolescents and young people who may find a daily intervention cumbersome.PrEP for AfricaIn sub-Saharan Africa, teenage girls and young women are most at risk of HIV infection. There are 2000 new infections in this group every week. These women are vulnerable because of the high prevalence of both gender-based violence and the commonality of age-disparate relationships and transactional sex. These conditions can make it difficult for women to negotiate safer sex practices. PrEP would enable these women to protect themselves in advance, without their partner’s knowledge or consent.Kenya and South Africa are the only two African countries that have granted regulatory approval for PrEP.New interventions can only be useful if deployed and scaled up to the populations most in need. This raises questions of cost versus impact. It is hoped that new formulations and delivery systems will enhance choice, encourage use, and provide a platform from which PrEP roll out can be advocated.Adherence is PrEP’s Achilles’ heelAdherence is key. To block HIV transmission PrEP must be “in the system” at the time of HIV exposure. Its effectiveness decreases rapidly when this “effective coverage” is inconsistent. Good adherence gives almost 100% HIV transmission prevention. Poor adherence results in little to no protection.This is why, where possible, a daily dose during times of risk is recommended. But this may be difficult to achieve for some.In PrEP trials the following reasons were given for poor adherence:fear/experience of side effects,fear of interactions with alcohol and other drugs,forgetfulness,dislike of pill-taking, andfear of the discrimination associated with taking an anti-HIV pill.Alternative dosing strategies using longer acting formulations and PrEP delivery methods may well be another way to increase PrEP effectiveness.New PrEP frontiersTopical gels, which can be applied pre and post sex to rectal and vaginal tissue, were the first alternative formulations to be tested. But the results in women have been inconsistent. This formulation still holds promise in men who have sex with men although efficacy trials haven’t yet been conducted.An alternative strategy is a monthly vaginal ring, which in its current form contains slow-release dapivirine (another antiretroviral). Two large phase III clinical trials have demonstrated that the ring is effective and can reduce the chance of HIV infection by 27%-31%. In a sub analysis of different ages, older women once again fared better than young women.The benefit of the vaginal ring is that there are less side effects because the drug is released locally and only a small amount enters the blood stream. The other huge plus is that women are encouraged to insert and forget, only changing the ring on a monthly basis. The obvious catch is that this is only suitable for women and vaginal intercourse.The vaginal ring is undergoing further investigation.Another tool that is being investigated and could overcome the need for a daily pill is a long-acting monthly injection. An injection of the antiretroviral cabotegravir (cabotegravir LA) has been shown to be very effective at lowering viral loads in people being treated for HIV when administered every two months.Also being investigated are dissolving vaginal films – a bit like the breath fresheners that can be bought over the counter – as well as quick dissolving pills.Perhaps most exciting of all is the prospect of an implant, a small rod which can be surgically placed just under the skin and will be able to slowly release antiviral protection over months.Finally, new formulations are currently being investigated that will combine treatment for both contraception and preventing sexually transmitted infections. It is hoped that these multifunctional preventions may further encourage people to consistently use these products.A new challenge to the field is how these new clinical trials can be efficiently designed. To qualify for first-line use of PrEP, new pills and products will need to have improved or equivalent efficacy compared to the current oral PrEP. And they would need to have reduced or equivalent side effects. All these formulations and delivery methods are still in the early stages of testing, but look to be out on the market within the next two to five years depending on their success.Linda-Gail Bekker is a professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town. The article was originally published in The Conversation. Read the original article.
The web’s thriving metropolis of video weirdness will soon host its very own real, live award show: The YouTube Music Awards. The event, coming on November 3, will take place on stage in New York and will be livestreamed around the world, in true YouTube fashion. Hosted by indie film darling Jason Schwartzman and directed by the perennially cool Spike Jonze, known best for his edgy music videos, YouTube is trying to out-hip the hip—and with big name guests like Lady Gaga, Eminem and Arcade Fire, it can probably succeed.But looking cool and putting together a star-studded show is merely the sound and fury. In recent days, Twitter and Facebook have both made some major plays in the social TV analytics space, which is red hot right now. Unlike those companies, Google can leverage its immense resources to craft its own Huge Live Event, broadcast over YouTube, soaking up Google+ user data. That could prove that not only is the third-most trafficked website in the world as relevant as ever—but that YouTube could be the most relevant force in the social TV space.That is, if it plays its cards right. Google Takes On … Everyone, ReallyForget Facebook and Twitter for a minute, if you will. With the YouTube Music Awards, Google’s big social TV move could have some symbolic collateral damage, namely to the stalwarts of the entertainment industry.MTV’s VMAs (don’t be caught dead saying “Video Music Awards”) have offered teens and twentysomethings a hip music awards alternative to the considerably more (literally) buttoned-up Grammys since 1984. If Miley Cyrus is any indication (and she is), the VMAs remain relevant after almost 30 years.But YouTube is more relevant. And because its content is user-created, that won’t be changing any time soon. YouTube is a strange confluence of mainstream artists (and their major labels) and Internet quirkiness ripe for memedom. Its unbridled randomness still thrives, and brands that manage to harness the social network’s odd energy and penchant for virality can thrive there. YouTube has sticking power—and its award show, just like the MTV VMAs 30-year-tenure, might too. Social TV Gets Hotter And HotterBeyond being big business for themselves, major award shows are big business for social networks, which see massive spikes in usage concurrent with live broadcast events. In 2012, the Grammy Awards drummed up 13 million “social media comments” on Twitter and Facebook, as tracked by social analytics firm Bluefin. The top three entertainment events that drummed up the most social buzz as of 2012 were music award shows. (That record was later bested by the 2012 election and the 2013 Super Bowl.) Tags:#music#YouTube taylor hatmaker 5 Outdoor Activities for Beating Office Burnout 9 Books That Make Perfect Gifts for Industry Ex… Related Posts 4 Keys to a Kid-Safe App 12 Unique Gifts for the Hard-to-Shop-for People… It’s no coincidence that Twitter bought Bluefin, the social analytics company conducting that very same research, earlier this year. There’s major money in insightful social data around viewing habits—and the more insight you can stockpile, the better. Twitter also partnered with Nielsen, the traditional TV ratings giant to add Twitter’s social TV analytics as a complement to Nielsen’s traditional viewership ratings. Meanwhile, Facebook will start selling its own social entertainment chatter to major networks like ABC, FOX, NBC and CBS, doled out in surely lucrative weekly reports.YouTube’s Social TV TrifectaThe intersection of streaming entertainment events and realtime social media activity is big business for the advertisers and content makers who can crack the code. And clearly, when it comes to social media, music award shows are some of the buzziest of all.If you’re Google, you’re sitting on a three ingredient formula for success: resources sufficient to craft your very own hyped-up award show, the online network to broadcast it over and, bettered by its recent splicing of Google+ DNA into YouTube comments, the social network to control the conversation.That’s not just major brand buzz and a ton of traffic—it’s a data goldmine.
Road Warriors sink Batang Pier “The emotions were high when it was 5-2,” she said. “I wanted to close it so much.”‘Unbelievable’ for StephensSpanish 12th seed Pablo Carreno Busta advanced to his second Grand Slam quarter-final with a 7-6 (7/2), 7-6 (7/4), 7-6 (7/3) victory over Shapovalov.The Canadian would have been the youngest Slam quarter-finalist since Michael Chang at the 1990 French Open, youngest US Open quarter-finalist since Andre Agassi in 1988 and first US Open qualifier in the last eight since Gilles Muller in 2008.“The biggest lesson is that I’m able to compete with these guys,” Shapovalov said. “I still think I have a lot of work to do.”Stephens, who was a 2013 Australian Open semi-finalist, missed 11 months with a foot injury that required surgery in January and returned only at Wimbledon, but has won 12 of her past 14 matches for her deepest US Open run in six tries.“I honestly couldn’t have asked for a better comeback,” Stephens said. “Making it to the quarter-finals here is unbelievable.”Wimbledon and Australian Open runner-up Venus Williams, the US ninth seed seeking her eighth Grand Slam title and third US Open crown, was to meet Spain’s Carla Suarez Navarro for a quarter-final spot.Wimbledon champion Garbine Muguruza, the third seed from Spain and leader in a fight for world number one, also was to face Czech 13th seed Petra Kvitova later.‘I just play perfect’Carreno Busta, the first player in Grand Slam history to face four qualifiers, has not dropped a set at the tournament.In a draw half assured of producing a first-time Slam finalist, he has a Tuesday quarter-final against either French 16th seed Lucas Pouille or Argentine 29th seed Diego Schwartzman. UPLB exempted from SEA Games class suspension Typhoon Kammuri accelerates, gains strength en route to PH Sharapova, whose five Grand Slam titles include the 2006 US Open, made 51 unforced errors to only 14 by Sevastova, whose 21 winners were half the 30-year-old Russian star’s total at Arthur Ashe Stadium.“She played unbelievable throughout the first and second set and I just kept fighting, running for every ball,” Sevastova said. “The third set could have gone either way.”FEATURED STORIESSPORTSWATCH: Drones light up sky in final leg of SEA Games torch runSPORTSSEA Games: Philippines picks up 1st win in men’s water poloSPORTSMalditas save PH from shutoutSevastova matched her best Slam run from last year’s US Open while 146th-ranked Sharapova served notice her game remains formidable, having defeated second-ranked Simona Halep in her dramatic opener on the New York hardcourts.Sharapova tested positive for the banned blood booster meldonium at the 2016 Australian Open and only returned from her suspension in April. She was snubbed for a French Open wildcard, missed Wimbledon with a thigh injury but received a wildcard for the US Open despite only one hardcourt tuneup match due to a left forearm injury.Sharapova blasted a backhand down-the-line winner to break for a 3-1 edge. Sevastova broke back in the seventh game but Sharapova broke again in the last, taking the first set after 27 minutes with a forehand crosscourt winner.But Sharapova hit a forehand wide to surrender a break to put the Latvian ahead 2-1 in the second set and Sevastova held from there, aided by Sharapova’s 16-2 edge in unforced errors in the set.Sharapova double faulted to hand Sevastova a break to open the final set and the Latvian broke again at love for a 3-0 lead.Sharapova then had a blistered right middle finger taped by a trainer and immediately broke back and held. But Sevastova held at love, broke again and took the match on a service winner.ADVERTISEMENT Don’t miss out on the latest news and information. MOST READ Catriona Gray spends Thanksgiving by preparing meals for people with illnesses Carreno Busta won his third career ATP title in May on Estoril clay then reached his first Slam quarter-final at the French Open, where he retired against Rafael Nadal with an abdominal injury that kept him out of Wimbledon.Shapovalov’s bid collapsed thanks to going 3-of-13 on break points and making 55 unforced errors against 54 winners, Carreno Busta with 25 winners against 29 unforced errors.“At the beginning I was a little bit discouraged, maybe nervous,” Carreno Busta said. “In the tie-breaks I just played perfect. It was an amazing victory for me.”Later men’s matches pitted South African 28th seed Kevin Anderson against Italy’s Paolo Lorenzi and German 23rd seed Mischa Zverev against US 17th seed Sam Querrey. CBB LATEST STORIES SEA Games in Calabarzon safe, secure – Solcom chief WATCH: Streetboys show off slick dance moves in Vhong Navarro’s wedding Read Next Kammuri turning to super typhoon less likely but possible — Pagasa Sports venues to be ready in time for SEA Games PLAY LIST 00:59Sports venues to be ready in time for SEA Games01:27Filipino athletes get grand send-off ahead of SEA Games00:50Trending Articles01:37Protesters burn down Iran consulate in Najaf01:47Panelo casts doubts on Robredo’s drug war ‘discoveries’01:29Police teams find crossbows, bows in HK university01:35Panelo suggests discounted SEA Games tickets for students02:49Robredo: True leaders perform well despite having ‘uninspiring’ boss02:42PH underwater hockey team aims to make waves in SEA Games Maria Sharapova of Russia (left) waves to the crowd after her women’s singles fourth round match loss to Anastasija Sevastova of Latvia (inset) on Day Seven of the 2017 US Open at the USTA Billie Jean King National Tennis Center on September 3, 2017. AFPNEW YORK, United States — Maria Sharapova’s Grand Slam comeback after a 15-month doping ban ended in defeat Sunday at the US Open, as did the dream run of Canadian 18-year-old Denis Shapovalov.Latvian 16th seed Anastasija Sevastova rallied to eliminate former world number one Sharapova 5-7, 6-4, 6-2 and book a quarter-final berth against American Sloane Stephens, who ousted Germany’s Julia Goerges 6-3, 3-6, 6-1.ADVERTISEMENT Brace for potentially devastating typhoon approaching PH – NDRRMC LOOK: Venues for 2019 SEA Games View comments